BETA

4 Amendments of Marlene MIZZI related to 2018/2108(INI)

Amendment 13 #
Draft opinion
Paragraph 1
1 Notes the benefits of Directive 2011/24/EU in clarifying the rules on cross-border healthcare and in ensuring access to safe and high-quality cross- border healthcare in the Union, as well as for achieving patient mobility in accordance with the case-law of the Court of Justice; urges Member States to ensure its proper implementation, guaranteeing a high level of public health protection that contributes to the improvement of citizens’ health, while respecting the principle of the free movement of persons within the internal market; stresses the focus of the Directive should be on addressing the imbalances between Member State healthcare and improving patients' rights rather than seeking to boost privatisation of the healthcare sector in different Member States in order to foster more market competition between healthcare providers within the single market.
2018/09/18
Committee: IMCO
Amendment 29 #
Draft opinion
Paragraph 3 a (new)
3 a. Notes the continued success of the European Health Insurance Card and the positive impact this has had on the lives of many who have made use of it throughout the EU and EEA.
2018/09/18
Committee: IMCO
Amendment 30 #
Draft opinion
Paragraph 3 b (new)
3 b. Notes that the Directive fundamentally is failing to address widening health inequalities across the EU and that those from poorer countries are still unable to access much-needed specialist treatment in other Member States.
2018/09/18
Committee: IMCO
Amendment 34 #
Draft opinion
Paragraph 5
5. Stresses the importance of information to patients about their rights and the procedures, costs and reimbursement rates in cross-border healthcare within the framework of Directive 2011/24/EU; invites the Commission to take measures to increase patients’ awareness about their rights and about the National Contact Points. Member States should collaborate to promote national safety and quality standards.
2018/09/18
Committee: IMCO